What antibodies should be checked for in autoimmune hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibody Testing for Autoimmune Hypoglycemia

For autoimmune hypoglycemia, the primary antibodies that should be tested are anti-insulin antibodies and anti-insulin receptor antibodies.

Types of Autoimmune Hypoglycemia

Autoimmune hypoglycemia can be classified into two main categories:

  1. Insulin Autoimmune Syndrome (IAS)

    • Characterized by anti-insulin antibodies
    • Also known as Hirata disease
    • More common in Asian populations, particularly Japanese
  2. Type B Insulin Resistance Syndrome

    • Characterized by anti-insulin receptor antibodies
    • Often associated with other autoimmune conditions

Specific Antibody Tests

For Insulin Autoimmune Syndrome:

  • Anti-insulin antibodies (IAA) 1, 2, 3, 4, 5
    • Should be measured using both:
      • Radioimmunoassay (RIA) - more sensitive
      • ELISA - complementary method as some cases may be missed by RIA alone 5

For Type B Insulin Resistance:

  • Anti-insulin receptor antibodies 1
    • Direct assay for antibodies directed against the insulin receptor

Diagnostic Approach

  1. Initial laboratory evaluation:

    • Document hypoglycemia (plasma glucose <70 mg/dL)
    • Measure insulin and C-peptide levels during hypoglycemic episode
    • Calculate insulin to C-peptide molar ratio (elevated ratio >1 suggests insulin antibodies) 4
  2. Confirmatory testing:

    • Polyethylene glycol (PEG) precipitation to detect antibody-bound insulin 5
    • Gel filtration chromatography (GFC) for definitive confirmation of antibody-bound insulin 5
    • Mass spectrometry for more accurate insulin quantification when antibodies are present 5

Clinical Pearls and Pitfalls

  • Key distinguishing features:

    • In IAS: spontaneous hypoglycemia with extremely high insulin levels (often >100 μU/mL) and detectable C-peptide 3, 4
    • Insulin to C-peptide molar ratio is typically markedly elevated (>1) 4
  • Common pitfalls:

    • Misdiagnosis as insulinoma leading to unnecessary invasive procedures 4
    • False interpretation of high insulin levels as exogenous insulin administration 1
    • Relying on a single antibody test method may miss some cases 5
  • Timing considerations:

    • IAS typically causes reactive hypoglycemia (several hours after meals) rather than fasting hypoglycemia 1
    • Anti-insulin receptor antibodies typically cause fasting hypoglycemia 1

Additional Considerations

  • Consider testing for other autoimmune conditions, as autoimmune hypoglycemia may be associated with other autoimmune disorders 6
  • HLA typing may be helpful as IAS has been associated with specific HLA types, particularly HLA-DR4 2

By systematically testing for these antibodies and following the diagnostic approach outlined above, autoimmune hypoglycemia can be accurately diagnosed and distinguished from other causes of hypoglycemia.

References

Research

The molecular specificity of insulin autoantibodies.

Diabetes/metabolism research and reviews, 2000

Research

Severe autoimmune hypoglycemia with insulin antibodies necessitating plasmapheresis.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2004

Research

Recurrent hypoglycemia from insulin autoimmune syndrome.

Journal of general internal medicine, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.